approval
saveLEQVIO (INCLISIRAN SODIUM) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 7
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalFeb 12, 2026 · 236d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalFeb 12, 2026 · 236d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalJun 6, 2024 · 852d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalJul 7, 2023 · 1187d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalFeb 17, 2023 · 1327d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalJun 6, 2022 · 1583d ago
- approvalLEQVIO (INCLISIRAN SODIUM) — FDA approvalDec 22, 2021 · 1749d ago
same company · ±60 days · 5
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalAug 6, 2025
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalAug 6, 2025
- approvalKESIMPTA: KESIMPTA (OFATUMUMAB) — FDA approvalAug 18, 2025
- approvalOXCARBAZEPINE: TRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 23, 2025
- approvalOXCARBAZEPINE: TRILEPTAL (OXCARBAZEPINE) — FDA approvalSep 23, 2025
comments(0)
5-min edit window · permanent after that